Top Markets
Coin of the day
Marvel Biosciences Corp. Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL
Rangering i aksjer #33329
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical... Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company’s lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer’s disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Aksjekurs
$0.12476927
Sist synkronisert: 2026-08-14
Markedsverdi
$7.86M
Endring (1 dag)
6.25%
Endring (1 år)
-19.80%
Land
CA
Handel Marvel Biosciences Corp. (MRVL)

Kategori

Aksjeprishistorikk for Marvel Biosciences Corp. (MRVL)
Høyeste sluttskurs: $0.12 den 2026-08-01

Laveste sluttskurs: $0.22 den 2021-07-01
Aksjeprishistorikk for Marvel Biosciences Corp. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 14.35%
2025 0.18%
2024 70.49%
2023 -36.24%
2022 -50.31%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$736.12 7.12%
CH
$1.07K -6.40%
KR
$255.38 13.33%
BE